94863-06-6

Basic information

• Product Name: benzyl 3-benzyloxy-2-nitrobenzoate
• Synonyms: benzyl 3-benzyloxy-2-nitrobenzoate
• CAS NO: 94863-06-6
• Molecular Weight: 363.37
• Mol File: 94863-06-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: benzyl 3-benzyloxy-2-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 3-benzyloxy-2-nitrobenzoate(94863-06-6)
• EPA Substance Registry System: benzyl 3-benzyloxy-2-nitrobenzoate(94863-06-6)

Safety Data

• Hazardous Substances Data: 94863-06-6(Hazardous Substances Data)

Upstream product

• 602-00-6 3-hydroxy-2-nitrobenzoic acid 
• 100-39-0 benzyl bromide 

Downstream Products

• 177477-46-2 4-[2,6-dimethyl-3-[N-[4-(methylcarbamoyl)cinnamoylglycyl]-N-methylamino]benzyloxy]-2-mercapto-1-methyl-1H-benzimidazole 
• 177478-40-9 3-[2,6-Dimethyl-3-[N-[4-(methylcarbamoyl)-cinnamoylglycyl]-N-methylamino]benzyloxy]-2-amino-N-methylaniline 
• 177477-27-9 4-[3-(N-Glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-2-methoxy-1-methyl-1H-benzimidazole 
• 177478-04-5 3-Benzyloxy-2-nitro-N-ethoxycarbonylacetyl-N-methylaniline 
• 177477-64-4 tert-butyl N-(3-benzyloxy-2-nitrophenyl)-N-ethylcarbamate 
• 177477-65-5 tert-Butyl N-(3-benzyloxy-2-nitrophenyl)-N-methylcarbamate 
• 177477-71-3 3-Benzyloxy-N-benzoyl-N-methyl-2-nitroaniline 
• 177477-63-3 tert-butyl 3-(benzyloxy)-2-nitrophenylcarbamate 
• 177478-00-1 3-benzyloxy-2-nitro-N-methoxyacetyl-N-methylaniline 
• 177478-05-6 (4-Benzyloxy-1-methyl-1H-benzoimidazol-2-yl)-acetic acid ethyl ester 

Relevant articles and documents

Diazepane derivatives or salts thereof

To provide a compound which has an anticoagulation action based upon inhibition of activated blood coagulation factor X and is useful as an anticoagulant or an agent for prevention and treatment of diseases caused by thrombus or embolus. A diazepan deriva

Benzimidazole compounds as bradykinin antagonists

PCT No. PCT/JP95/01478 Sec. 371 Date Feb. 3, 1997 Sec. 102(e) Date Feb. 3, 1997 PCT Filed Jul. 25, 1995 PCT Pub. No. WO96/04251 PCT Pub. Date Feb. 15, 1996This invention relates to a heterocyclic compound of the formula: wherein a group of the formula: is a group of the formula: etc., X is O, S or N-R5, R1 is lower alkyl, etc., R5 is hydrogen, lower alkyl, etc., R2 is hydrogen, halogen, lower alkyl, etc., R3 is halogen, lower alkyl, etc., R4 is amino optionally having suitable substituent(s), and A is lower alkylene, and a salt thereof, to processes for preparation thereof, and to a pharmaceutical composition comprising the same for the prevention and/or the treatment of bradykinin or its analogues mediated diseases in human being or animals.